Safety and Effectiveness of Propagermanium in Focal Segmental Glomerulosclerosis Participants Receiving Irbesartan

PHASE2CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

November 8, 2018

Primary Completion Date

June 16, 2020

Study Completion Date

July 13, 2020

Conditions
Focal Segmental Glomerulosclerosis
Interventions
DRUG

Propagermanium

Immediate release capsule

DRUG

Placebo

Placebo capsule

Trial Locations (11)

2065

Royal North Shore Hospital, St Leonards

2145

Westmead, Westmead

2170

Liverpool Hospital, Liverpool

2250

Renal Research, Gosford

3021

Sunshine Hospital, Melbourne

3084

Austion Hospital, Heidelberg

3121

Epworth Hospital, Richmond

3128

Box Hill Hospital, Box Hill

4102

Princess Alexandra Hospital, Woolloongabba

4575

Sunshine Coast University Hospital, Birtinya

Unknown

Melbourne Renal Research Group, Melbourne

Sponsors
All Listed Sponsors
collaborator

Iqvia Pty Ltd

INDUSTRY

lead

Dimerix Bioscience Pty Ltd

INDUSTRY